We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




A Wire Mesh Hugs the Failing Heart

By HospiMedica staff writers
Posted on 25 Feb 2008
An innovative cardiac ventricular support system delivered by a minimally invasive procedure slows or halts the enlargement of the heart associated with heart failure (HF).

The HeartNet ventricular elastic support system is comprised of an elastic nickel-titanium (nitinol) mesh that wraps around and reinforces the walls of the heart, covering the failing heart ventricles of patients in advanced stages of HF. More...
The mesh provides permanent, gentle support that is designed to reinforce the walls of the heart to slow or stop the enlargement process and enable the heart to work more efficiently, ultimately decreasing the debilitating symptoms of heart failure. Because each patient is physically different, the device comes in various sizes; based on results from a non-invasive echocardiogram that shows the actual size of the heart, the appropriate size device is chosen for each patient. Early findings have shown that the HeartNet may not only improve heart function and exercise capacity, but also decreases left ventricular (LV) dyssynchrony and helps restore regional homogeneity of the ventricular contraction.

The device is delivered via a minithoracotomy, a minimally invasive procedure that takes about one hour from start to finish; the patient does not need to be placed on heart-lung bypass for the surgery. Since the surgeons apply a gentle mechanical support to the failing heart without actually opening the patient's chest, recovery time typically only takes three weeks. When coupled with other heart failure therapies such as medication, the HeartNet may help return patients to their desired lifestyle. Currently limited to investigational use, the HeartNet ventricular elastic support system was developed by Paracor Medical (Sunnyvale, CA, USA).

"We are excited about the HeartNet's potential as a less invasive surgical approach to permanently assist weakened or failing heart muscles,” said Stephen A. Olenchock, Jr., M.D., a cardiac surgeon at Caritas St. Elizabeth's Medical Center (Boston, MA, USA), which is participating in the Prospective Evaluation of Elastic Restraint to LESSen the Effects of Heart Failure (PEERLESS-HF) trial of the HeartNet. "The advanced heart failure team is encouraged by our early observations and we will see if the HeartNet restores more normal function in diseased hearts without major open heart surgery, potentially reducing the need for more invasive procedures.”


Related Links:
Paracor Medical
Caritas St. Elizabeth's Medical Center

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.